IVERIC bio Stock Forecast, Price & News

IVERIC bio (NASDAQ:ISEE) Frequently Asked Questions

Is IVERIC bio a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IVERIC bio in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" IVERIC bio stock.
View analyst ratings for IVERIC bio or view top-rated stocks.

How has IVERIC bio's stock been impacted by Coronavirus (COVID-19)?

IVERIC bio's stock was trading at $4.46 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ISEE shares have increased by 216.1% and is now trading at $14.10.
View which stocks have been most impacted by COVID-19.

When is IVERIC bio's next earnings date?

IVERIC bio is scheduled to release its next quarterly earnings announcement on Wednesday, March 2nd 2022.
View our earnings forecast for IVERIC bio.

How were IVERIC bio's earnings last quarter?

IVERIC bio, Inc. (NASDAQ:ISEE) posted its quarterly earnings data on Monday, November, 8th. The company reported ($0.23) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.06. During the same period in the prior year, the company earned ($0.27) earnings per share.
View IVERIC bio's earnings history.

What price target have analysts set for ISEE?

3 Wall Street analysts have issued 1 year price targets for IVERIC bio's shares. Their forecasts range from $18.00 to $26.00. On average, they anticipate IVERIC bio's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 56.0% from the stock's current price.
View analysts' price targets for IVERIC bio or view top-rated stocks among Wall Street analysts.

Who are IVERIC bio's key executives?

IVERIC bio's management team includes the following people:

• Glenn P. Sblendorio, Chief Executive Officer & Director
• Pravin U. Dugel, President (LinkedIn Profile)
• Keith Westby, Chief Operating Officer & Senior Vice President
• David F. Carroll, Chief Financial Officer, Treasurer & Senior VP
• Abraham Scaria, Chief Scientific Officer

What is Glenn Spina's approval rating as IVERIC bio's CEO?

6 employees have rated IVERIC bio CEO Glenn Spina on Glassdoor.com. Glenn Spina has an approval rating of 41% among IVERIC bio's employees. This puts Glenn Spina in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of IVERIC bio's key competitors?

Some companies that are related to IVERIC bio include Legend Biotech (LEGN), Zai Lab (ZLAB), BridgeBio Pharma (BBIO), Blueprint Medicines (BPMC), HUTCHMED (HCM), Ultragenyx Pharmaceutical (RARE), Perrigo (PRGO), Cerevel Therapeutics (CERE), Mawson Infrastructure Group (WIZP), I-Mab (IMAB), Allakos (ALLK), Arvinas (ARVN), Ionis Pharmaceuticals (IONS), Apellis Pharmaceuticals (APLS) and Alkermes (ALKS).
View all of ISEE's competitors.

What other stocks do shareholders of IVERIC bio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IVERIC bio investors own include Pfizer (PFE), Inovio Pharmaceuticals (INO), Novavax (NVAX), Maxar Technologies (MAXR), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Alibaba Group (BABA), Cisco Systems (CSCO) and Kinross Gold (KGC).

What is IVERIC bio's stock symbol?

IVERIC bio trades on the NASDAQ under the ticker symbol "ISEE."

Who are IVERIC bio's major shareholders?

IVERIC bio's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.45%), Perceptive Advisors LLC (6.52%), Deerfield Management Company L.P. Series C (4.67%), Commodore Capital LP (2.64%), Invesco Ltd. (2.03%) and Geode Capital Management LLC (1.57%). Company insiders that own IVERIC bio stock include Christopher Paul Simms, David R Guyer, Glenn Sblendorio, Keith Westby and Pravin Dugel.
View institutional ownership trends for IVERIC bio.

Which institutional investors are selling IVERIC bio stock?

ISEE stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Deerfield Management Company L.P. Series C, Altium Capital Management LP, Tamarack Advisers LP, Monarch Partners Asset Management LLC, HighVista Strategies LLC, Barclays PLC, and Citigroup Inc.. Company insiders that have sold IVERIC bio company stock in the last year include David R Guyer, Keith Westby, and Pravin Dugel.
View insider buying and selling activity for IVERIC bio or view top insider-selling stocks.

Which institutional investors are buying IVERIC bio stock?

ISEE stock was bought by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Invesco Ltd., Polar Capital Holdings Plc, Two Sigma Investments LP, BlackRock Inc., Commodore Capital LP, Voloridge Investment Management LLC, and Lion Point Capital LP. Company insiders that have bought IVERIC bio stock in the last two years include Christopher Paul Simms, and Glenn Sblendorio.
View insider buying and selling activity for IVERIC bio or or view top insider-buying stocks.

How do I buy shares of IVERIC bio?

Shares of ISEE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IVERIC bio's stock price today?

One share of ISEE stock can currently be purchased for approximately $14.10.

How much money does IVERIC bio make?

IVERIC bio has a market capitalization of $1.62 billion. The company earns $-84.55 million in net income (profit) each year or ($1.11) on an earnings per share basis.

How many employees does IVERIC bio have?

IVERIC bio employs 57 workers across the globe.

What is IVERIC bio's official website?

The official website for IVERIC bio is ivericbio.com.

Where are IVERIC bio's headquarters?

IVERIC bio is headquartered at ONE PENN PLAZA 35TH FLOOR, NEW YORK NY, 10119.

How can I contact IVERIC bio?

IVERIC bio's mailing address is ONE PENN PLAZA 35TH FLOOR, NEW YORK NY, 10119. The company can be reached via phone at (212) 845-8200 or via email at [email protected].